1. Home
  2. CRGX vs CCBG Comparison

CRGX vs CCBG Comparison

Compare CRGX & CCBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • CCBG
  • Stock Information
  • Founded
  • CRGX 2021
  • CCBG 1895
  • Country
  • CRGX United States
  • CCBG United States
  • Employees
  • CRGX N/A
  • CCBG N/A
  • Industry
  • CRGX
  • CCBG Major Banks
  • Sector
  • CRGX
  • CCBG Finance
  • Exchange
  • CRGX Nasdaq
  • CCBG Nasdaq
  • Market Cap
  • CRGX 628.6M
  • CCBG 625.1M
  • IPO Year
  • CRGX 2023
  • CCBG N/A
  • Fundamental
  • Price
  • CRGX $3.70
  • CCBG $37.72
  • Analyst Decision
  • CRGX Hold
  • CCBG Buy
  • Analyst Count
  • CRGX 7
  • CCBG 2
  • Target Price
  • CRGX $4.67
  • CCBG $39.00
  • AVG Volume (30 Days)
  • CRGX 1.9M
  • CCBG 26.6K
  • Earning Date
  • CRGX 03-20-2025
  • CCBG 01-28-2025
  • Dividend Yield
  • CRGX N/A
  • CCBG 2.47%
  • EPS Growth
  • CRGX N/A
  • CCBG 1.63
  • EPS
  • CRGX N/A
  • CCBG 3.12
  • Revenue
  • CRGX N/A
  • CCBG $230,883,000.00
  • Revenue This Year
  • CRGX N/A
  • CCBG N/A
  • Revenue Next Year
  • CRGX N/A
  • CCBG $3.97
  • P/E Ratio
  • CRGX N/A
  • CCBG $11.94
  • Revenue Growth
  • CRGX N/A
  • CCBG 4.53
  • 52 Week Low
  • CRGX $3.00
  • CCBG $25.45
  • 52 Week High
  • CRGX $33.92
  • CCBG $40.86
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 20.88
  • CCBG 58.74
  • Support Level
  • CRGX $3.00
  • CCBG $35.44
  • Resistance Level
  • CRGX $3.88
  • CCBG $37.91
  • Average True Range (ATR)
  • CRGX 0.92
  • CCBG 1.08
  • MACD
  • CRGX -1.00
  • CCBG 0.25
  • Stochastic Oscillator
  • CRGX 5.99
  • CCBG 92.10

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About CCBG Capital City Bank Group

Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.

Share on Social Networks: